PAR5 ADALIMUMAB, ETANERCEPT OR INFLIXIMAB- WHAT IS THE MOST COST-EFFECTIVE ANTI-TNF-á THERAPY IN RA IN A REAL-WORLD SETTING?

Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)64920-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)64920-0/fulltext
Section Title :
Section Order : 79
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64920-0&doi=10.1016/S1098-3015(10)64920-0
HEOR Topics :
Tags :
Regions :